# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093856
Filing Date
2024-08-08
Accepted
2024-08-08 16:01:31
Documents
67
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | scyx-20240630.htm iXBRL | 10-Q | 1901104
2 | EX-31.1 | scyx-ex31_1.htm | EX-31.1 | 16740
3 | EX-31.2 | scyx-ex31_2.htm | EX-31.2 | 17248
4 | EX-32.1 | scyx-ex32_1.htm | EX-32.1 | 10694
| Complete submission text file | 0000950170-24-093856.txt |  | 9512289

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | scyx-20240630.xsd | EX-101.SCH | 1198094
69 | EXTRACTED XBRL INSTANCE DOCUMENT | scyx-20240630_htm.xml | XML | 2215079

Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 241188037
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)